Nevertheless, OX40 co-stimulatory signaling can re-invigorate exhausted CD8+ T cells, restoring their proliferative potential and cytokine production while favoring IFN-γ expression in tumor-infiltrating immune cells, associated with favorable patient prognosis in small-cell lung cancer (SCLC) [71]. This evidence concerns the gene CD8A and neoplasm.